Effect of FID 114675A on Lens Wettability

NCT01342107 — Not applicable, Completed, 66 participants, Alcon Research

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Effect of Alcon Multi-Purpose Disinfecting Solution (MPDS) on Lens Wettability

RegistryNCT01342107
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, single group, masking: double, supportive care
Enrollment66 (Actual)
SponsorAlcon Research (Industry)
ConditionsContact Lens Wettability
InterventionsFID 114675A multi-purpose disinfecting solution (MPDS), Soft contact lens, Blister pack solution (Device)
Datesstart 2010-12-01, primary completion 2011-02-01, completion 2011-02-01, first posted 2011-04-27, last updated 2012-04-13
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Contact Lens Wettability All trials of FID 114675A multi-purpose disinfecting solution (MPDS) All trials of Soft contact lens

-Summary

The purpose of this study is to evaluate lens wettability of contact lenses when used with an investigational multi-purpose disinfecting solution.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
FID 114675AExperimentalDevice: FID 114675A multi-purpose disinfecting solution (MPDS); Device: Soft contact lensContact lens soaked overnight in an investigational multi-purpose disinfecting solution randomly assigned to one eye, with contact lens removed directly from the blister pack assigned to the fellow eye for contralateral wear. Both products worn for one day, 16 hours.
Blister PackActive comparatorDevice: Soft contact lens; Device: Blister pack solutionContact lens removed directly from the blister pack randomly assigned to one eye, with contact lens soaked overnight in an investigational multi-purpose disinfecting solution assigned to the fellow eye for contralateral wear. Both products worn for one day, 16 hours.
  • FID 114675A multi-purpose disinfecting solution (MPDS) (Device): Investigational multi-purpose disinfecting solution intended for use as a cleaning, reconditioning, rinsing, disinfecting, and storage solution for silicone hydrogel and soft contact lenses.
  • Soft contact lens (Device), also known as Acuvue2, PureVision, Acuvue Oasys: Soft hydrogel or silicone hydrogel contact lens matching subject's pre-study lens, including parameters, worn 16 hours on day of dispense.
  • Blister pack solution (Device), also known as Acuvue2, PureVision, Acuvue Oasys: Commercially approved storage solution as found in the contact lens blister pack.

+Outcome measures

Primary outcomes

  • Lens Wettability [16 hours]: As assessed by the investigator during slit-lamp exam and rated on a 0-4 scale, with 0 = a smooth uniformly reflecting wettable surface; 1 = a coarse hazy wettable surface which seems resolved momentarily with each blink and becomes exacerbated with staring; 2 = one stable dry (non-wetting) area of some magnitude; 3 = more than one stable dry (non-wetting) area of some magnitude; 4 = non-wettable lens surface of severe magnitude. Lenses with a Grade 0 or 1 were rated as wettable and reported as a percentage of total lenses evaluated.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* 18 years or age or older with normal eyes, other than correction for refractive error.
* At least 5 days successful daily wear (minimum 8 hours per day) of PureVision®, Acuvue® Oasys™, or Acuvue® 2 contact lenses prior to Visit 1
* Vision correctable to 20/30 (Snellen) or better in each eye at distance with lenses at Visit 1 (Day 0 - Baseline).
* Grade 0 or Grade 1 wettability in both eyes after at least 15 minutes of lens wear at Visit 1 (Day 0 - Baseline).
* Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

* Any ocular or systemic medical condition that may, in the opinion of the investigator, preclude safe administration of the test articles or affect the results of the study.
* Need to wear contact lenses on an extended wear basis (i.e., overnight) during the study.
* Use of products other than a multi-purpose solution or hydrogen peroxide solution, including daily and enzyme cleaners and saline rinses, for lens care at least 7 days prior to Visit 1 (Day 0 - Baseline).
* Use of over-the-counter (OTC) or prescribed topical ocular medications within 7 days prior to Visit 1. Use of lens rewetting drops is acceptable.
* History or current ocular infections or ocular inflammatory events.
* Ocular surgery within the past year.
* Participation in any investigational study within the past 30 days.
* Other protocol-defined exclusion criteria may apply.

+Posted results

Participant flow

MilestoneFID 114675ABlister Pack
Started3432
Completed3432
Not completed00

Outcome results

  • Lens Wettability (Primary), Number, percentage of lenses: FID 114675A 95.5 (87.3 to 99.1); Blister Pack 97.0 (89.5 to 99.6)

Adverse events

Time frame: Adverse events were collected for the duration of the study: October 11, 2010 through February 2, 2011.

ArmDeathsSerious adverse eventsOther adverse events
FID 114675A00/66 (0.0%)0/66 (0.0%)
Blister Pack00/66 (0.0%)0/66 (0.0%)

+Locations (1)

FacilityCityCountryStatus
Contact Alcon Call Center for Trial LocationsFort Worth, TexasUnited States